A short repost of a review line noting substantial weight loss in people without diabetes, plus growing oral and multi-agonist options. No source details given.
Recap by typeshit. Post by @scientists.ideas.sciences on Instagram.
In mice, GLP-1 receptor signaling mainly calmed inflammation while GLP-2 receptor signaling helped the intestine repair after T cell attack, researchers report.
Talker Research polled 2,000 Americans for aesthetics company Revance. Of 1,402 GLP-1 users, over 24% reported a new identity shift after starting the drugs.
Raw numbers pointed to higher AMD risk with GLP-1 drugs, but researchers say the pattern reversed once heart and metabolic factors were accounted for.
The Havre de Grace center opened a research building and will test whether the pairing cuts alcohol cravings. The study starts in early 2027, results about two years later.
The anatomy channel argues the hollowed look isn't a direct drug side effect but what quick fat loss does to the face. A full breakdown is up on YouTube.
A short explainer on whether the hollow look called Ozempic face comes from losing fat or from the drug itself.
Loading…